logo
Select company
Select metric
7.47%Debt to Assets Ratio
VS
Market
69
Sector
60
Industry
49
History
52
$ 0.78Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information

Ticker

STRO

Company Name

SUTRO BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SUTRO BIOPHARMA INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STRO - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 262.36M$ 19.59M7.47%
3/31/2025$ 321.43M$ 21.4M6.66%
12/31/2024$ 387.21M$ 23.15M5.98%
9/30/2024$ 451.83M$ 24.86M5.5%
6/30/2024$ 489.04M$ 26.53M5.42%
3/31/2024$ 403.4M$ 28.07M6.96%
12/31/2023$ 470.74M$ 33.63M7.15%
9/30/2023$ 431.73M$ 38.17M8.84%
6/30/2023$ 464.9M$ 42.66M9.18%
3/31/2023$ 358.02M$ 46.56M13.01%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) Debt to Assets stands at 7.95%.
  • Over the past 5 years, SUTRO BIOPHARMA INC's average Debt to Assets has been 9.79%.
  • The median Debt to Assets for SUTRO BIOPHARMA INC during this period was 7.71%
  • SUTRO BIOPHARMA INC reached its highest Debt to Assets over the past 5 years at 19.09%.
  • The lowest Debt to Assets recorded by SUTRO BIOPHARMA INC in the same timeframe 5.42%

SUTRO BIOPHARMA INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
IPSC : CENTURY THERAPEUTICS INC 16.36%IGMS : IGM BIOSCIENCES INC 0%FBIO : FORTRESS BIOTECH INC 43.29%DOMH : DOMINARI HOLDINGS INC 2.62%MGX : METAGENOMI INC 15.79%ASRT : ASSERTIO HOLDINGS INC 14.26%LUNG : PULMONX CORP 38.61%KPTI : KARYOPHARM THERAPEUTICS INC 181.75%ICCC : IMMUCELL CORP 30.53%ATRA : ATARA BIOTHERAPEUTICS INC 150.8%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for SUTRO BIOPHARMA INC is calculated as follows: Debt [ $ 24.41M ] / Assets [ $ 307.24M ]
(=) Debt to Assets [ 7.95% ]

STRO - Debt to Assets Ratio, Last 5 years

5.42%

Minimum

Jun 30, 2024

19.09%

Maximum

Mar 31, 2022

9.79%

Average

7.71%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.34% with a standard deviation of 24.52%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.34%
median21.09%
std24.52%